Afatinib for the treatment of metastatic non-small cell lung cancer

av Joshi, Monika, Rizvi, Syed M, Belani, Chandra P
I publikationen Cancer Manag Res (2015)

Targeted immunotherapy for non-small cell lung cancer

av Vasekar, Monali, Liu, Xin, Zheng, Hong, Belani, Chandra P
Publicerad 2014

EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer

av Rice, Shawn J., Liu, Xin, Wang, Hong-Gang, Belani, Chandra P.
I publikationen PLoS One (2019)

Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer

av Joshi, Monika, Rice, Shawn J., Liu, Xin, Miller, Bruce, Belani, Chandra P.
I publikationen PLoS One (2015)

Posttraumatic Symptoms, Quality of Life, and Survival among Lung Cancer Patients

av Dougall, Angela Liegey, Swanson, Jeffrey, Kyutoku, Yasushi, Belani, Chandra P., Baum, Andrew
I publikationen J Appl Biobehav Res (2017)

What is the role of maintenance therapy in the treatment of non-small cell lung cancer?

av Jiang, Yixing, Owonikoko, Taofeek K., Ramalingam, Suresh S., Khuri, Fadlo R., Belani, Chandra P.
Publicerad 2010

Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury

av Rice, Shawn J., Hyland, Victoria, Behera, Madhusmita, Ramalingam, Suresh S., Bunn, Paul, Belani, Chandra P.
I publikationen J Thorac Oncol (2020)

Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells

av Owonikoko, Taofeek K., Ramalingam, Suresh S., Kanterewicz, Beatriz, Balius, Trent, Belani, Chandra P., Hershberger, Pamela A.
Publicerad 2010

A rewiring model of intratumoral interaction networks

av Sang, Mengmeng, Rice, Shawn, Jiang, Libo, Liu, Xin, Gragnoli, Claudia, Belani, Chandra P., Wu, Rongling
I publikationen Comput Struct Biotechnol J (2019)

Phase II study of Belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma

av Ramalingam, Suresh S., Belani, Chandra P., Ruel, Christopher, Frankel, Paul, Gitlitz, Barbara, Koczywas, Marianna, Espinoza-Delgado, Igor, Gandara, David
Publicerad 2009

Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis

av Behera, Madhusmita, Owonikoko, Taofeek K., Chen, Zhengjia, Kono, Scott A., Khuri, Fadlo R., Belani, Chandra. P., Ramalingam, Suresh S.
Publicerad 2012

Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504)

av Ramalingam, Suresh S., Lee, Ju-Whei, Belani, Chandra P., Aisner, Seena C., Kolesar, Jill, Howe, Craig, Velasco, Mario R., Schiller, Joan H.
Publicerad 2011

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Fou...

av Burris, Howard A., Belani, Chandra P., Kaufman, Peter A., Gordon, Alan N., Schwartzberg, Lee S., Paroly, Warren S., Shahin, Seta, Dreiling, Lyndah, Saven, Alan
Publicerad 2010

Phase II study of cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (NCI # 7097)

av Ramalingam, Suresh S., Belani, Chandra P., Mack, Philip C., Vokes, Everett E., Longmate, Jeffrey, Govindan, Ramaswamy, Koczywas, Marianna, Ivy, S. Percy, Gandara, David R.
Publicerad 2010

Expression of PD-1 on CD4(+) T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer

av Zheng, Hong, Liu, Xin, Zhang, Jianhong, Rice, Shawn J., Wagman, Matthias, Kong, Yaxian, Zhu, Liuluan, Zhu, Junjia, Joshi, Monika, Belani, Chandra P.
I publikationen Oncotarget (2016)

Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer

av Ji, Cheng, Zhang, Li, Cheng, Yan, Patel, Raj, Wu, Hao, Zhang, Yi, Wang, Mian, Ji, Shundong, Belani, Chandra P, Yang, Jin-Ming, Ren, Xingcong
Publicerad 2014

Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer

av Belani, Chandra P, Nemunaitis, John J, Chachoua, Abraham, Eisenberg, Peter D, Raez, Luiz E, Cuevas, J Daniel, Mather, Cecile B, Benner, Rebecca J, Meech, Sandra J
Publicerad 2013

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer

av Belani, Chandra P, Yamamoto, Nobuyuki, Bondarenko, Igor M, Poltoratskiy, Artem, Novello, Silvia, Tang, Jie, Bycott, Paul, Niethammer, Andreas G, Ingrosso, Antonella, Kim, Sinil, Scagliotti, Giorgio V
Publicerad 2014

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tum...

av Ramanathan, Ramesh K., Egorin, Merrill J., Erlichman, Charles, Remick, Scot C., Ramalingam, Suresh S., Naret, Cynthia, Holleran, Julianne L., TenEyck, Cynthia J., Ivy, S. Percy, Belani, Chandra P.
Publicerad 2010

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients with Advanced Malignancies

av Zamboni, William C., Ramalingam, Suresh, Friedland, David M., Edwards, Robert P., Stoller, Ronald G., Strychor, Sandra, Maruca, Lauren, Zamboni, Beth A., Belani, Chandra P., Ramanathan, Ramesh K.
Publicerad 2009